Current Surgical Indications for Non-Small-Cell Lung Cancer
With recent strides made within the field of thoracic oncology, the management of NSCLC is evolving rapidly. Careful patient selection and timing of multi-modality therapy to permit the optimization of therapeutic benefit must be pursued. While chemotherapy and radiotherapy continue to have a role i...
Main Authors: | Nathaniel Deboever, Kyle G. Mitchell, Hope A. Feldman, Tina Cascone, Boris Sepesi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/5/1263 |
Similar Items
-
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumorsCentral MessagePerspective
by: Terrance Peng, MD, MPH, et al.
Published: (2022-06-01) -
Outcomes of Completion Lobectomy for Locoregional Recurrence after Sublobar Resection in Patients with Non-small Cell Lung Cancer
by: Cho Eun Lee, et al.
Published: (2024-03-01) -
Sublobar resection versus lobectomy in the treatment of synchronous multiple primary lung cancer
by: Niu Niu, et al.
Published: (2023-04-01) -
Quality of life after lung cancer surgery: sublobar resection versus lobectomy
by: Shuai Jiang, et al.
Published: (2023-11-01) -
Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched Analysis
by: Shuncang Zhu, et al.
Published: (2022-07-01)